Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Apple
AAPL
US OptionsDetailed Quotes
VSTM250516C13000
- 0.00
- 0.000.00%
15min DelayClose Apr 30 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest13.00Strike Price0.00Turnover0.00%IV73.56%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier16DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma14.98Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Verastem Stock Discussion
Sign in to post a comment
$Verastem (VSTM.US)$
Verastem Oncology Announces $75M Private Placement
Verastem Inc - to Sell $24 Million in Common Stock at $7.00 per Share
Verastem Oncology Announces $75M Private Placement
Verastem Inc - to Sell $24 Million in Common Stock at $7.00 per Share
1
1
$Verastem (VSTM.US)$ Verastem Oncology Announces $75M Private Placement expected to close April 28
Benzinga· just
Benzinga· just
1
$Verastem (VSTM.US)$
Verastem Oncology Announces $75 million Private Placement
26 seconds ago, 6:00 AM PDT
Via BusinessWire
Verastem Oncology (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that it has entered into a securities purchase agreement with certain institutional and accredited investors for a private placement of approximately $24 million of shares of its common stock at a price of $7...
Verastem Oncology Announces $75 million Private Placement
26 seconds ago, 6:00 AM PDT
Via BusinessWire
Verastem Oncology (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that it has entered into a securities purchase agreement with certain institutional and accredited investors for a private placement of approximately $24 million of shares of its common stock at a price of $7...
1
$Verastem (VSTM.US)$
Revolutionary KRAS G12D Cancer Drug Gets FDA Green Light Following Promising Patient Responses
Revolutionary KRAS G12D Cancer Drug Gets FDA Green Light Following Promising Patient Responses
$Verastem (VSTM.US)$ Reuters· 15 mins ago
Verastem Oncology Announces U.S. Ind Clearance of Vs-7375, Oral Kras G12D (on/off) Inhibitor, Enabling Phase 1/2a Trial in Advanced Solid Tumors
Verastem Oncology Announces U.S. Ind Clearance of Vs-7375, Oral Kras G12D (on/off) Inhibitor, Enabling Phase 1/2a Trial in Advanced Solid Tumors
1
2
$Verastem (VSTM.US)$
Verastem Oncology's Strategic Move: 247K Share Package Ties New Talent to Sales Goals
Verastem Oncology's Strategic Move: 247K Share Package Ties New Talent to Sales Goals
$Verastem (VSTM.US)$
Revolutionary Cancer Drug Achieves Complete Response in Colorectal Cancer Study
Revolutionary Cancer Drug Achieves Complete Response in Colorectal Cancer Study
$Verastem (VSTM.US)$
FDA Fast-Tracks Verastem's Cancer Drug as Company Reports $151M Cash Position
FDA Fast-Tracks Verastem's Cancer Drug as Company Reports $151M Cash Position
$Verastem (VSTM.US)$
Can This New Ovarian Cancer Drug Transform Treatment? Key Data Reveals Breakthrough Potential
Can This New Ovarian Cancer Drug Transform Treatment? Key Data Reveals Breakthrough Potential
No comment yet
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
72055196 : good news or bad boss